BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11835393)

  • 1. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
    Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
    Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
    Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
    J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
    Ahmed N; Riley C; Oliva K; Rice G; Quinn M
    Br J Cancer; 2005 Apr; 92(8):1475-85. PubMed ID: 15798771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
    Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
    Xue B; Wu W; Huang K; Xie T; Xu X; Zhang H; Qi C; Ge J; Yu Y
    Mol Cell Biochem; 2013 Aug; 380(1-2):177-84. PubMed ID: 23615713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
    Yang WL; Godwin AK; Xu XX
    Cancer Res; 2004 Feb; 64(4):1534-40. PubMed ID: 14973065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
    Ge X; Fu YM; Meadows GG
    Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
    Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
    Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
    Brogley MA; Cruz M; Cheung HS
    J Cell Physiol; 1999 Aug; 180(2):215-24. PubMed ID: 10395291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
    Benasciutti E; Pagès G; Kenzior O; Folk W; Blasi F; Crippa MP
    Blood; 2004 Jul; 104(1):256-62. PubMed ID: 15031204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
    Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S; New L; Pan Z; Han J; Nemerow GR
    J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
    J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
    Saldanha RG; Molloy MP; Bdeir K; Cines DB; Song X; Uitto PM; Weinreb PH; Violette SM; Baker MS
    J Proteome Res; 2007 Mar; 6(3):1016-28. PubMed ID: 17330942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.